Genital Lichen Sclerosus in Girls Under 18: When Topical Corticosteroids Are Insufficient

This protocol applies to girls under 18 years of age with genital lichen sclerosus in whom initial first-line therapy with topical corticosteroids has not achieved adequate control of signs and symptoms.

Previous Treatment & Failure Condition

First-line management in girls with genital LS uses ultrapotent or potent topical corticosteroids — including clobetasol propionate or mometasone furoate — co-administered with topical emollients. When this approach fails to achieve suppression of the signs and symptoms of LS, escalation to a next-line protocol is warranted.

Next-Line Approach (Partial Overview)

The structured next-line protocol for this population incorporates a specific class of topical immunomodulatory agents, used as a second-choice therapy or alongside prior treatment when corticosteroids are insufficient. The complete regimen — agent selection, sequencing, and maintenance considerations — is available in full via the protocol link below.

Treatment goal: Complete response of symptoms and signs — achieved in 36% of patients at 8 weeks and 64% at 16 weeks.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1111/jdv.20083

We recommend ultrapotent or potent topical corticosteroids in girls with genital lichen sclerosus.

We suggest topical calcineurin inhibitors in girls with genital lichen sclerosus as second choice or as an additional treatment if topical corticosteroids are contraindicated or insufficient. (off label)

Fourteen prepubertal girls (4–11 years) with anogenital LS were treated with 0.03% tacrolimus ointment twice daily for 16 weeks; then, 9 of the 14 patients adhered to 2 times weekly for further 6 months (a total of 10 months).

TCIs may be used for maintenance therapy in girls after initial treatment with topical clobetasol 0.05% once or twice daily for several weeks.

Complete response of symptoms and signs was achieved in 5 (36%), 9 (64%) and 11 (79%) patients at 8 weeks, 16 weeks and 10 months, respectively.

View source ↗